Zobrazeno 1 - 10
of 35
pro vyhledávání: '"MJ Seminerio"'
Publikováno v:
Value in Health. 25:S419-S420
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b356ca9e67a408835a01f4dea8851454
https://doi.org/10.1016/j.jval.2022.04.681
https://doi.org/10.1016/j.jval.2022.04.681
Publikováno v:
Value in Health. 25:S338
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62df091a154c9a25a1c5aa32a71aad36
https://doi.org/10.1016/j.jval.2022.04.271
https://doi.org/10.1016/j.jval.2022.04.271
Publikováno v:
Value in Health. 25:S346
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a6e0d9e24ba05c74c5e086f731b5ec6
https://doi.org/10.1016/j.jval.2022.04.1745
https://doi.org/10.1016/j.jval.2022.04.1745
Publikováno v:
Value in Health. 25:S325
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d161278499477b793201066120a480c
https://doi.org/10.1016/j.jval.2022.04.210
https://doi.org/10.1016/j.jval.2022.04.210
Autor:
Buse DC; Department of Neurology, Albert Einstein College of Medicine, New York, NY, USA., Krasenbaum LJ; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Seminerio MJ; Teva Branded Pharmaceuticals, Parsippany, NJ, USA., Packnett ER; Merative, Ann Arbor, MI, USA., Carr K; Teva Branded Pharmaceuticals, Parsippany, NJ, USA., Ortega M; Teva Branded Pharmaceuticals, Parsippany, NJ, USA., Driessen MT; Teva Pharmaceuticals, Piet Heinkade 107, 1019 BR, Amsterdam, Netherlands. Maurice.Driessen@Tevaeu.com.
Publikováno v:
Pain and therapy [Pain Ther] 2024 Jun; Vol. 13 (3), pp. 511-532. Date of Electronic Publication: 2024 Mar 12.
Autor:
Rhyne C; Diamond Headache Clinic, Chicago, IL., Cohen JM; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA., Seminerio MJ; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA., Carr K; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA., Krasenbaum LJ; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA.
Publikováno v:
Medicine [Medicine (Baltimore)] 2023 Jun 09; Vol. 102 (23), pp. e33874.
Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments.
Autor:
Nissan GR; North Texas Institute of Neurology & Headache, Plano, TX 75024, USA., Kim R; Premier Health Clinical Neuroscience Institute and Department of Internal Medicine and Neurology, Wright State University Boonshoft School of Medicine, Dayton, OH 45409, USA., Cohen JM; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA 19380, USA., Seminerio MJ; Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, USA., Krasenbaum LJ; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA 19380, USA., Carr K; Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, USA., Martin V; Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2022 Jul 27; Vol. 11 (15). Date of Electronic Publication: 2022 Jul 27.
Autor:
Lampl C; Department of Neurology and Headache Medical Centre, Konventhospital Barmherzige Brüder Linz, Linz, Austria., Rapoport AM; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Cohen JM; Global Medical Affairs, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, Pennsylvania, USA., Barash S; Statistics, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, Pennsylvania, USA., Ramirez Campos V; Global Medical Affairs, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, Pennsylvania, USA., Seminerio MJ; North American Medical Affairs, Teva Pharmaceuticals USA, Inc., Parsippany, New Jersey, USA., Ning X; Global Clinical Development, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, Pennsylvania, USA., Silberstein SD; Jefferson Headache Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Publikováno v:
European journal of neurology [Eur J Neurol] 2022 Jul; Vol. 29 (7), pp. 2129-2137. Date of Electronic Publication: 2022 Mar 29.
Autor:
Driessen MT; Teva Pharmaceuticals, Piet Heinkade 107, 1019 BR, Amsterdam, The Netherlands. Maurice.Driessen@Tevaeu.com., Cohen JM; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Thompson SF; Teva Pharmaceuticals, Parsippany, NJ, USA., Patterson-Lomba O; Analysis Group, Boston, MA, USA., Seminerio MJ; Teva Pharmaceuticals, Parsippany, NJ, USA., Carr K; Teva Pharmaceuticals, Parsippany, NJ, USA., Totev TI; Analysis Group, Boston, MA, USA., Sun R; Analysis Group, Boston, MA, USA., Yim E; Analysis Group, Boston, MA, USA., Mu F; Analysis Group, Boston, MA, USA., Ayyagari R; Analysis Group, Boston, MA, USA.
Publikováno v:
The journal of headache and pain [J Headache Pain] 2022 May 16; Vol. 23 (1), pp. 56. Date of Electronic Publication: 2022 May 16.
Autor:
Lipton RB; Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA., Cohen JM; Global Medical Affairs, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Galic M; Global Medical Affairs, Teva Pharmaceuticals Europe B.V., Amsterdam, The Netherlands., Seminerio MJ; North America Medical Affairs, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Yeung PP; Global Medical Affairs, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Aycardi E; Global Medical Affairs, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Bigal ME; Research and Development, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Bibeau K; Global Medical Affairs, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Buse DC; Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.
Publikováno v:
Headache [Headache] 2021 Apr; Vol. 61 (4), pp. 662-672.